RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • January 23rd, 2009 • Biodelivery Sciences International Inc • Pharmaceutical preparations • England
This Research Collaboration and License Agreement (the “Agreement”) is made as of January 20, 2009. (the “Effective Date”), by and between BioDelivery Sciences International, Inc., a corporation having its principal place of business at 801 Corporate Center, Suite 210, Raleigh, North Carolina 27607, USA (“BDSI”), and THE DRUGS FOR NEGLECTED DISEASES INITIATIVE, a not-for-profit foundation organized under the laws of Switzerland, having its registered office at 15 chemin Louis-Dunant, 1202 Geneva, Switzerland (“DNDi”). BDSI and DNDi are referred to herein each individually as a “Party” and collectively as the “Parties.”
